Catapult Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-8,015	Closed	-$505K	–	160
2015 Q2	$505K	Sell	8,015 -8,015	-50%	-$505K	0.07%	155
2015 Q1	$771K	Buy	+16,030	New	+$771K	0.09%	145